Herpes/SARS-CoV-2 Treatment with Micellized Nutraceuticals

Abstract

In natural immunity, infected cells express part of the viral protein on their cell surface. The host's natural killer cells (NKC) recognize and directly kill the infected cells. Therefore, an antiviral drug can block any virus' steps to reproduce itself. Using the NutraNanoSphere™ technology platform, a significant array of potent antivirals nutraceuticals have been incorporated into the TriAntiVP™ (antivirus and parasite) micellized formulation. These include Curcumin, Artemisinin, Bilberry, and Vitamin D 3 as core components. These supplements have little of any side effects and are good candidates to be taken on a daily basis to prevent parasitic and viral diseases. While the use of these nutraceuticals has been hindered therapeutically because of their low aqueous solubility and rapid degradation in the stomach, the micellization process significantly increases the bioavailability.These active supplements fight against viral disease, e.g., COVID-19 or HERPES, collectively by preventing the binding of the viral S protein to the ACE2 receptor on lung cells, thus preventing the infection process, inhibiting the protolytic processes that allow replicating viruses to leave the host cell, prevents NF-ĸB cytokine storm inflammatory results, inhibits viral protein processing, enables one to immediately be proactive when an initial diagnosis of a skin lesion, such as herpes, or viral illness. We think we have effective preventative formulations and treatments by combining a range of antiviral nutraceuticals to the NutraNanoSphere™ delivery system. The versatility of these treatments allows for oral medication, applying antivirals directly in the nasopharynx, and topically attacking the lesions on the skin.